Nasdaq: TPST

Tempest Therapeutics, Inc. (TPST)

Tempest Therapeutics, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker TPST. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
TPST
Exchange
Nasdaq
SEC CIK
1544227
Official filings
SEC EDGAR

Research TPST

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Tempest Therapeutics, Inc.'s stock ticker?

Tempest Therapeutics, Inc. trades under the ticker symbol TPST on Nasdaq. Its SEC Central Index Key (CIK) is 1544227.

Where can I read Tempest Therapeutics, Inc.'s SEC filings?

The TPST SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Tempest Therapeutics, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze TPST's financial statements?

The TPST Financials page shows Tempest Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does TPST compare with its peers and the market?

The TPST Peer Comparison page lines Tempest Therapeutics, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.